We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$255M
AUM Growth
+$14.4M
Cap. Flow
-$8.4M
Cap. Flow %
-3.29%
Top 10 Hldgs %
35.01%
Holding
130
New
5
Increased
33
Reduced
56
Closed

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Financials 15.15%
3 Healthcare 14.52%
4 Consumer Staples 13.13%
5 Consumer Discretionary 12.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$208B
$3.39M 1.33%
19,402
+300
+2% +$53.1K
COP icon
27
ConocoPhillips
COP
$147B
$3.16M 1.24%
57,355
-657
-1% -$33.8K
KMB icon
28
Kimberly-Clark
KMB
$36.3B
$2.93M 1.15%
24,234
+2
+0% +$233
CSX icon
29
CSX Corp
CSX
$93.4B
$2.88M 1.13%
156,987
-606
-0.4% -$10.7K
TFX icon
30
Teleflex
TFX
$6.05B
$2.79M 1.09%
11,137
-397
-3% -$99.8K
TECH icon
31
Bio-Techne
TECH
$11.2B
$2.6M 1.02%
79,880
-3,344
-4% -$106K
MRK icon
32
Merck
MRK
$322B
$2.59M 1.01%
48,046
-2,122
-4% -$118K
CMI icon
33
Cummins
CMI
$87.5B
$2.57M 1.01%
14,505
+50
+0.3% +$8.55K
CPRT icon
34
Copart
CPRT
$27B
$2.53M 0.99%
233,488
-6,688
-3% -$65.1K
CMP icon
35
Compass Minerals
CMP
$1.23B
$2.48M 0.97%
34,251
-309
-0.9% -$20.8K
ZBRA icon
36
Zebra Technologies
ZBRA
$14B
$2.45M 0.96%
23,373
-150
-0.6% -$16.3K
BMS
37
DELISTED
Bemis
BMS
$2.38M 0.93%
49,717
+2,459
+5% +$114K
MDXG icon
38
MiMedx Group
MDXG
$602M
$2.34M 0.92%
184,923
-29,077
-14% -$355K
SON icon
39
Sonoco
SON
$5.57B
$2.18M 0.86%
41,070
-632
-2% -$33.1K
DVN icon
40
Devon Energy
DVN
$52.1B
$2.18M 0.85%
52,543
-2,527
-5% -$95.6K
PFE icon
41
Pfizer
PFE
$143B
$2.18M 0.85%
63,247
-839
-1% -$28.6K
AFL icon
42
Aflac
AFL
$64.9B
$2.13M 0.83%
48,402
+922
+2% +$39.4K
DUK icon
43
Duke Energy
DUK
$97.8B
$2.03M 0.8%
24,167
+28
+0.1% +$2.45K
PAYX icon
44
Paychex
PAYX
$41.6B
$2.01M 0.79%
29,538
-647
-2% -$42.5K
MDP
45
DELISTED
Meredith Corporation
MDP
$2M 0.78%
30,160
-575
-2% -$34.7K
GL icon
46
Globe Life
GL
$14.2B
$1.68M 0.66%
18,498
-429
-2% -$36.8K
MMM icon
47
3M
MMM
$90.9B
$1.45M 0.57%
7,353
-63
-0.8% -$12.1K
LEG icon
48
Leggett & Platt
LEG
$1.34B
$1.39M 0.55%
29,139
+4,324
+17% +$204K
JWN
49
DELISTED
Nordstrom
JWN
$1.26M 0.49%
26,473
+1,058
+4% +$45.6K
EMR icon
50
Emerson Electric
EMR
$83.9B
$1.11M 0.43%
15,862
-94
-0.6% -$6.09K

Similar funds

Rowlandmiller & Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Rowlandmiller & Partners held 130 positions worth $255M, up 6% from $241M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Rowlandmiller & Partners withdrew a net $8.4M in Q4 2017, reducing 56 holdings. Its largest reduction was Berkshire Hathaway Class B, cutting an estimated $9.09M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Rowlandmiller & Partners opened a new position in Bank of New York Mellon worth $124K.

  • Rowlandmiller & Partners's largest Q4 2017 buy was Bank of New York Mellon: 2,293 shares worth $124K.
  • Rowlandmiller & Partners added most to Truist Financial in Q4 2017, an estimated $5.24M increase.
  • Rowlandmiller & Partners's biggest Q4 2017 reduction was Berkshire Hathaway Class B, cutting an estimated $9.09M.
  • Rowlandmiller & Partners's ten largest holdings make up 35% of its $255M portfolio in Q4 2017.
  • Rowlandmiller & Partners opened 5 new positions and closed 0 in Q4 2017.
  • Rowlandmiller & Partners's portfolio value rose 6% quarter-over-quarter to $255M.

Based on Rowlandmiller & Partners's 13F filing for Q4 2017, filed 11 Jan 2018.